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Abstract
We present diagnostic criteria for motion sickness, visually induced motion sickness (VIMS), motion 
sickness disorder (MSD), and VIMS disorder (VIMSD) to be included in the International Classification 
of Vestibular Disorders. Motion sickness and VIMS are normal physiological responses that can be 
elicited in almost all people, but susceptibility and severity can be high enough for the response to be 
considered a disorder in some cases. This report provides guidelines for evaluating signs and symptoms 
caused by physical motion or visual motion and for diagnosing an individual as having a response that is 
severe enough to constitute a disorder. 
The diagnostic criteria for motion sickness and VIMS include adverse reactions elicited during exposure 
to physical motion or visual motion leading to observable signs or symptoms of greater than minimal 
severity in the following domains: nausea and/or gastrointestinal disturbance, thermoregulatory 
disruption, alterations in arousal, dizziness and/or vertigo, headache and/or ocular strain. These 
signs/symptoms occur during the motion exposure, build as the exposure is prolonged, and eventually 
stop after the motion ends.  Motion sickness disorder and VIMSD are diagnosed when recurrent 
episodes of motion sickness or VIMS are reliably triggered by the same or similar stimuli, severity does 
not significantly decrease after repeated exposure, and signs/symptoms lead to activity modification, 
avoidance behavior, or aversive emotional responses.  
2
Motion sickness/MSD and VIMS/VIMSD can occur separately or together. Severity of symptoms in 
reaction to physical motion or visual motion stimuli varies widely and can change within an individual 
due to aging, adaptation, and comorbid disorders. We discuss the main methods for measuring motion 
sickness symptoms, the situations conducive to motion sickness and VIMS, and the individual traits 
associated with increased susceptibility. These additional considerations will improve diagnosis by 
fostering accurate measurement and understanding of the situational and personal factors associated with 
MSD and VIMSD.  
1. Introduction
The Classification Committee of the Bárány Society was charged with establishing standardized 
international clinical diagnostic criteria for motion sickness and visually induced motion sickness 
(VIMS) and when these conditions constitute disorders. These criteria were developed by an 
international group of vestibular specialists, scientists, and therapists for the Bárány Society in order to 
promote a common reference frame across disciplines involved in the care of the general public and of 
individuals with high susceptibility to motion sickness and VIMS. Though a common phenomenon, 
sickness induced by physical motion of the person or visual motion can adversely affect otherwise 
healthy individuals and decrease safety in situations that require high levels of concentration. The 
establishment of these criteria recognizes that motion sickness and VIMS, while being normal 
physiologic responses, can have profound negative effects when symptoms are severe, and can 
sometimes be considered a motion sickness disorder (MSD) or visually induced motion sickness 
disorder (VIMSD). 
1.1 History
Descriptions of motion induced sickness date back to 400 BCE, becoming more common as modes of 
transportation advanced with time. Ancient Greek texts mention symptoms of seasickness such as 
nausea, vomiting, faintness, difficulty concentrating, and lack of initiative which are still considered 
valid today [1].  Theories to explain such reactions to motion evolved over the centuries from pre-
scientific ideas to later explanations concerning the effects of inner ear overstimulation or disrupted 
multisensory integration [1-3]. It has long been known that the vestibular organs are implicated in 
seasickness [4] and that people without vestibular function are not susceptible to motion sickness, even 
during highly sickening sea conditions [5]. Modern interest in the mechanisms, treatment, and 
prevention of motion sickness grew dramatically in the early 20th century due to the unprecedented 
number of military troops being transported by sea, air, and land. The initiation of space travel in the 
1960s further spurred interest in motion sickness research, fostering some of the assessment tools and 
countermeasures that are used today [6]. 
Motion sickness that is mainly caused by stimulation of the visual system, often in the absence of 
physical motion, has received increased recognition recently [7, 8]. Symptoms of VIMS were reported 
as early as the 19th century in the haunted swing amusement ride and documented during adaptation to 
visual rearrangement and subsequent readaptation to normal vision [9-11]. These early reports noted 
symptoms such as dizziness, nausea, and vertigo, each of which is still featured today in the most 
widely-used simulator sickness state questionnaire [12]. Modern scientific studies of VIMS were first 
documented in the 1950s in the laboratory and the military domains when optokinetic stimuli and flight 
simulators were found to cause motion sickness-like symptoms (nausea, dizziness, 
vertigo/disorientation, blurred vision, headache, and drowsiness) [13-17]. Due to recent technological 
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advancements, visual displays and applications have become pervasive (surround theaters, vehicle 
simulators, virtual reality, augmented reality), making VIMS a common phenomenon. 
1.2 Theories 
Motion sickness and VIMS are polysymptomatic syndromes driven by the interaction between a specific 
stimulus and individual susceptibility. While there is no single, universally accepted theory of motion 
sickness or VIMS, several hypotheses exist concerning the evolutionary origins and immediate etiology 
of motion sickness and VIMS [6, 7, 17-21].
The sensory conflict/neural mismatch hypothesis of motion sickness is the most cited explanation. It 
posits that motion sickness is caused by a conflict between expected versus actual interactions among 
visual, vestibular, and somatosensory inputs [6, 18]. This conflict can be due to dissonance among 
different sensory modalities, intra-vestibular mismatch between canal and otolith inputs, mismatch 
between current multisensory input versus multisensory calibrations acquired during past stimuli, and/or 
a discrepancy between the perceived and actual orientation of the gravitational upright [19-22]. Motion 
sickness has also been hypothesized to be a by-product of the abnormal activation of vestibulo-
autonomic pathways by physical or apparent motion to which the human nervous system is unable to or 
has not had sufficient time to adapt [23, 24]. These theories predict that motion sickness will diminish 
with repeated exposure if the challenging motions are sufficiently within one’s adaptive capacity and the 
internal model of expected sensory input recalibrates. 
The toxin hypothesis of motion sickness is a variant of the sensory conflict theory which attempts to 
explain the evolutionary origins of the characteristic symptoms of motion sickness (e.g., nausea, 
vomiting) rather than the immediate cause of the motion sickness reaction during a given stimulus [25]. 
This hypothesis postulates that motion-induced vomiting is an accidental, modern (transportation-
related) by-product of an ancient evolutionarily protective response to the neural effects of various 
toxins which are often associated with distortions of sensory input. Thus, sensory integration 
disturbances and neural effects are produced by modern motion which are similar to ancient responses 
triggered by poisoning (e.g., from spoiled meat, toxic plants, animal venom, or even intoxicants such as 
fermented fruit) [17]. A shared susceptibility to triggering the emetic pathway by different mechanisms 
is supported by the observation that individuals with high motion sickness susceptibility are more likely 
to suffer from nausea and vomiting from other causes, such as chemotherapy and actual toxins [26]. 
However, many tenets of the toxin hypothesis have been questioned and modified. 
The direct evolutionary hypothesis posits that ancient physical or apparent motions existed that could 
have contributed directly to the evolution of aversive reactions, without the need for accidental co-
opting of a poison response via the neural effects of modern transportation [17]. Nevertheless, the direct 
poisoning hypothesis posits that the body's poison response system shaped some of the signature motion 
sickness symptoms that emerged during the direct evolution of aversive reaction to certain ancient 
motions. 
Finally, the possibility has been raised that motion sickness is simply an unfortunate structural 
consequence of the proximity of anatomical pathways that mediate vestibular signals with those that 




Members of the Classification Committee of the Bárány Society (CCBS) met in Berlin, Germany in 
March 2017 and proposed the creation of a subcommittee to develop criteria for motion sickness for the 
International Classification of Vestibular Disorders (ICVD). They selected a Chairperson (YHC) to 
choose subcommittee members who represented a broad range of subspeciality expertise and who came 
from three different continents. Subcommittee communication occurred through email and subsequent 
meetings. The CCBS met again to discuss its progress before the 30th Bárány Society meeting in 
Uppsala, Sweden in June 2018, and in Berlin, Germany in November 2019. Diagnostic criteria were 
developed through discussions among subcommittee members. Draft criteria were presented to the 
CCBS in November 2019 and then modified based on comments.  A revised draft was made available 
for comment by the Bárány Society membership in January 2020. Further comments and concerns were 
addressed before publication.
2.2 Selection of symptoms for criteria
The diagnostic criteria described in this report are derived from a large body of studies that have 
categorized motion sickness symptoms and have contributed to the development of well-validated 
motion sickness metrics. The categorization of the symptoms of motion sickness and VIMS was initially 
driven by military and space exploration needs to include pre-vomiting symptoms. Vomiting, while 
objective, is usually a late sign of motion sickness and is impractical for assessing escalating severity of 
motion sickness and VIMS. The identification of earlier symptoms broadened the spectrum of severity 
of motion sickness and led to recognition of when interventions were needed to stop the progression of 
sickness. By the 1940s, some of the most common symptoms beyond obvious vomiting or retching were 
agreed upon by multiple authors (e.g., cold sweating, pallor), leading to a full diagnostic checklist 
containing multiple motion sickness symptoms developed by the 1960s [29-31]. 
The three most influential multi-symptom motion sickness state questionnaires include: 1) the Simulator 
Sickness Questionnaire/Motion Sickness Questionnaire (SSQ/MSQ) [12], 2) the Pensacola Diagnostic 
Index (PDI) (most-cited in [32], and fully matured in [31]), and 3) the Motion Sickness Assessment 
Questionnaire (MSAQ) [33]. The complete 28-item MSQ and the 16-items focused on simulator 
sickness that make up the SSQ portion have been cited more than any other motion sickness state 
questionnaires and are relevant to the development of other motion sickness scales (e.g. MSAQ[33], 
Misery Scale [34]). In order to form a more manageable and easily remembered set of criteria, however, 
the major items of the MSQ/SSQ and the PDI have been grouped. Cross-referencing the most agreed-
upon symptoms across multiple formal motion sickness/VIMS diagnostic categorization efforts 
produced the motion sickness/VIMS criteria below and detailed in Tables 1-3.
3. Diagnostic Criteria 
3.1 Motion Sickness and Visually Induced Motion Sickness
Motion sickness is diagnosed when the sickness inducing stimulus is physical motion of the person; 
visually induced motion sickness (VIMS) is diagnosed when the stimulus is visual motion. An acute 
episode of motion sickness/VIMS is sickness induced by physical motion/visual motion that 
meets Criteria A through D:
A. Physical motion of the person1 or visual motion2 elicits sign(s) and/or symptom(s) in at least one of 
the following categories, experienced at greater-than-minimal severity: 
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1. Nausea and/or gastrointestinal disturbance3
2. Thermoregulatory disruption4
3. Alterations in arousal5
4. Dizziness and/or vertigo6
5. Headache and/or ocular strain7 
B. Sign(s)/Symptom(s) appear during motion and build as exposure is prolonged8
C. Sign(s)/Symptom(s) eventually stop after cessation of motion9
D. Sign(s)/Symptom(s) are not better accounted for by another disease or disorder10 
COMMENTS:
Nausea and/or gastrointestinal disturbance can include a feeling of sickness with an urge to vomit, 
retching, actual vomiting, epigastric/stomach discomfort/awareness, change in salivation and/or appetite, 
burping, and a desire to move bowels. Thermoregulatory disruption can include sweating/cold sweating, 
clamminess, flushing, warmth, and pallor. Alterations in arousal can include drowsiness, fatigue, 
tiredness, and difficulty concentrating. Dizziness and/or vertigo can include these symptoms as well as 
disorientation, faintness, and visual motion illusions. Headache and/or ocular strain can include head 
pain, head fullness, eyestrain, difficulty focusing, and blurred vision.  Blurred vision can also occur in 
the context of vertigo.  The presence of a greater number of signs and/or symptoms allows greater 
specificity that symptoms are due to motion sickness. 
NOTES:
1. A variety of physical motion stimuli can trigger motion sickness. While highly susceptible people 
tend to be susceptible to multiple motion stimuli, susceptibility to one type of stimulus does not 
necessarily correlate with susceptibility to others for an entire group of people. Examples of sickening 
motion stimuli include:
a. Water transportation, e.g., ships, boats, rafts, submarines, floating, snorkeling, scuba-diving
b. Air transportation, e.g., airplanes, helicopters, hang-gliding, parasailing, skydiving, parabolic 
flight
c. Land transportation, e.g., cars, trains, trucks, buses, off-road vehicles (including armored 
vehicles), self-driving cars, and some forms of animal-based transportation (e.g., camels)
d. Amusement devices, e.g., amusement park rides, playground motion devices, certain swings 
or hammocks
e. Swaying buildings, e.g., low frequency wind or tremor-induced sway, especially in tall 
buildings 
f. Vestibular stimulation in laboratory settings, e.g., Coriolis cross-coupling, off-vertical axis 
rotation (OVAR), horizontal or vertical low frequency linear oscillation, and certain stimuli 
aboard human centrifuges
g. Space travel, e.g., upon entering orbit or first returning to Earth
2. Visual stimulation may be presented via virtual/augmented reality devices, simulators, movies, 
computer monitors, dynamic video games, or optokinetic drums. Even certain small mobile displays can 
be disturbing under certain conditions (e.g., display parallax wherein foreground and background move) 
or when viewed while walking or riding in a vehicle. When visually-triggered motion sickness also 
includes physical motion, e.g., motion-based flight simulators, driving simulators, or ship simulators, the 
contributions of both forms of stimuli should be noted.
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3. Many of these symptoms and others in the criteria have been formally defined [12, 17]. Stomach 
awareness and discomfort are common early gastric manifestations of motion sickness.  The unpleasant 
sensations can include the esophageal or epigastric areas. Nausea may be mild or severe. Though the 
probability of vomiting is generally related to the severity of nausea, vomiting may rarely occur at low 
or negligible levels of nausea without much warning in some situations, or in very susceptible people 
[35]. Prolonged mild or moderate nausea can occasionally lead to an ‘avalanche’ phenomenon in which 
symptoms rapidly escalate to vomiting [36]. If vomiting occurs during a severe stimulus, it generally 
happens within 60-minutes of the onset of other symptoms, such as moderate or severe nausea [23, 37]. 
Vomiting is not as common with VIMS as with physical motion, partially because affected individuals 
can close their eyes before symptoms become severe. Nausea and related symptoms should be 
distinguishable by the clinician from primary gastric disorders and anxiety.
4. When due to motion sickness, sweating is generally a ‘cold’ sweat that can accompany other 
autonomic signs and symptoms. The sweating is ‘cold’ because it occurs in the absence of a rise in 
ambient temperature, not because it is always experienced as cold clamminess. In fact, it is often 
preceded by a sudden warm sensation in the face, neck, and/or upper chest. Sweating due to motion 
sickness in a warm environment should be distinguishable from ambient thermal causes (e.g., by 
suddenness of onset). Pallor is almost always present in some combination prior to vomiting [38]. 
However, an individual’s recollection concerning pallor depends upon others to mention it for the 
individual to observe it (e.g., in a mirror). Therefore, a recollection of pallor should be weighed heavily 
by clinicians but failing to recollect the presence of pallor is inconclusive.
5. Symptoms such as fatigue, drowsiness, or difficulty concentrating are part of the full list of 28 
SSQ/MSQ symptoms and are considered to be suggestive of the ‘sopite’ syndrome [39]. Several other 
symptoms related to poor mood or reduced motivation have been inferred to be sopite-related during 
prolonged motion tests [39], and symptoms such as fuzzy/foggy-headed, lazy/unmotivated, and relaxed 
have been endorsed by research participants recollecting situations involving mild motion [17, 40]. 
Fatigue due to motion sickness should be distinguishable from sleep deprivation, physical exhaustion, or 
other disorders causing lethargy.  
6. When due to motion sickness, these symptoms should not be solely attributable to vestibular 
disorders, changes in atmospheric pressure, postural hypotension, or visual cliffs [41]. Feelings of 
vertigo or spinning can also be elicited without motion sickness during piloting an aircraft without good 
visual references or experiencing a visually induced illusion of self-motion. When an episode of vertigo 
leads to overlapping symptoms with motion sickness, these symptoms are considered sequelae of the 
vertigo spell and not a separate motion sickness syndrome. However, clinicians should be aware of 
differences between the ICVD and the motion sickness literature, the latter of which established its 
symptom definitions prior to the ICVD. The ICVD defines dizziness as disturbed or distorted orientation 
without a sense of motion [42], whereas in motion sickness research, dizziness is not always defined or 
has a definition that does not exclude illusions of self-motion. Similarly, the ICVD defines vertigo as, “a 
sensation of self-motion when no self-motion is occurring or the sensation of distorted self-motion 
during an otherwise normal head movement,” [42] whereas in motion sickness research, vertigo usually 
means a loss of orientation with respect to the vertical upright [12]. The ICVD definition of internal 
vertigo does not explicitly distinguish among illusions of angular motion, linear motion, or tilt. Applying 
the ICVD definition of vertigo to the motion sickness literature, vertigo certainly can be induced by 
motion stimuli which elicit motion sickness. The most widely used laboratory protocol for the controlled 
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elicitation of severe motion sickness (Coriolis cross-coupling during constant velocity rotation in the 
dark) repeatedly elicits a temporary illusion of distorted self-tilt displacement (and an even greater 
illusion of self-velocity) during otherwise normal head movements. Similarly, illusions of velocity and 
displacement can be caused by high-speed turns, low-frequency horizontal linear oscillation, viewing 
large optokinetic fields, decelerating after non-pendular centrifugation, various flight illusions (e.g., 
leans, somatogravic, G-excess), and terrestrial readaptation following spaceflight, most of which can 
cause motion sickness [41, 43]. For these reasons, it is best for clinicians not to assume that a report of 
frank vertigo is evidence against motion sickness having occurred in a person without vestibular 
pathology. 
Visually induced dizziness (VID) is recognized as a sense of spatial disorientation caused by moving or 
visually complex stimuli and is time-locked to the stimulus, ie. the onset is immediate with the onset of 
the visual stimulus. Dizziness in VIMS is phenomenologically indistinguishable from VID, but the onset 
will often be delayed and build in intensity with continued exposure. While whole-field motion is known 
to readily elicit an illusion of self-motion (called vection), this illusion is neither necessary nor sufficient 
for VIMS to occur [17]. Nevertheless, a large field moving in the roll (x-axis) of the head can cause a 
compelling sensation of self-motion consistent with vection [44].
7. Greater susceptibility to motion sickness and VIMS occurs in individuals with migraine or vestibular 
migraine (See section 4.5.1) but headaches triggered by motion are not necessarily migraine headaches 
[45]. Though motion sickness and VIMS symptoms typically resolve quickly after the motion stops, 
headache can persist until specifically treated. Headache may be more common and occur more 
frequently without nausea in VIMS than in motion sickness caused by physical motion. A secondary 
symptom, head fullness, is relevant as well, since it is a similar symptom that has emerged frequently in 
simulator or cybersickness studies. Eyestrain/discomfort, difficulty focusing, and visual blurring are 
particularly common symptoms of VIMS [7, 8]. Eye/visual symptoms should be distinguishable from 
visual overwork or ocular/visual disorders. Blurred vision may also accompany vertigo, and not always 
imply ocular dysfunction, however.
8. Symptoms that start immediately with movement or are maximal at the onset of motion should raise 
suspicion for a possible disorder (vestibular for physical motion, ocular or visual-vestibular for visual 
motion), an anxiety reaction, or an aversively conditioned response wherein past motion sickness has led 
to classical conditioning to the sight and smell of the situation. Strong stimuli in very susceptible 
individuals may induce symptoms with very little temporal delay. Continued exposure within the 
individual’s adaptive capacity may also lead to habituation and eventual reduction of sickness.
9. Although some symptoms of motion sickness or VIMS may persist after termination of the stimulus, 
the onset of sickness symptoms must occur during the motion stimulus and not begin exclusively after 
the stimulus has ended. This distinguishes motion sickness from mal de débarquement syndrome, which 
only begins once the motion has ended and lasts for at least 48-hours [46]. 
10. Motion sickness and VIMS may co-occur and symptom severity may be exacerbated by the presence 
of ocular motility disorders, visual-vestibular disorders, or vestibular disorders such as vestibular 
migraine, vestibular neuritis, or persistent postural perceptual dizziness. In these situations, both a 
diagnosis of motion sickness or VIMS and the contributing disorder should be made. 
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3.2. Motion Sickness Disorder and Visually Induced Motion Sickness Disorder
Motion sickness disorder (MSD) is diagnosed when the sickness inducing stimulus is physical motion; 
visually induced motion sickness disorder (VIMSD) is diagnosed when the stimulus is visual motion. 
MSD or VIMSD is diagnosed when Criteria A through E are met:
A. At least five episodes of motion sickness/VIMS triggered by the same or similar motion stimuli1,2,3
B. Sign(s)/Symptom(s) are reliably triggered by the same or similar motion stimuli4
C. Sign(s)/Symptom(s) severity does (do) not significantly decrease after repeated exposure to the same 
or similar motion stimuli5
D. Sign(s)/Symptom(s) lead to one or more of the following behavioral or emotional responses6
a. Activity modification to abort sickness sign(s)/symptom(s)
b. Avoidance of the motion stimulus that triggers sickness
c. Aversive anticipatory emotions prior to exposure to the motion stimulus
E. Sign(s)/Symptom(s) are not better accounted for by another disease or disorder7
COMMENTS: 
1. Probable MSD/VIMSD can be diagnosed if two to four episodes have occurred. 
2. On a population level and in the absence of certain disorders that impact vestibular function (see 
Section 4.5) motion sickness susceptibility typically peaks during youth and adolescence and 
declines with age. Defining whether the symptoms refer to the ≤12-year range or the >12-year 
range will help in accurate communication of current status and in determination of prognostic 
variables. Based on a simplified scoring system of the MSSQ, the Pearson correlation between 
recollected childhood (Part A) and adult motion sickness susceptibility (Part B) is r = .65 [47, 
48].  
NOTES:
3. Susceptibility to motion sickness or VIMS from one type of stimulus may not predict reactions 
to other types of stimuli. Therefore, motion sickness and VIMS to each motion stimulus (e.g., 
airplanes, automobiles, boats, virtual reality systems, simulators) should be considered separately 
(see Notes 1&2, Section 3.1)
4. The induction of motion sickness and VIMS can be specific to a particular transportation 
situation, e.g., the individual may only feel sick on small boats but not large ships, smaller 
propellor aircraft but not large jetliners, etc. Similarly, the induction of VIMS may be specific to 
a particular head-mounted virtual reality display, simulator, or viewing screen. 
5. Susceptibility to motion sickness and VIMS usually declines with repeated exposures, with the 
rate of adaptation being dependent upon many factors including the strength or predictability of 
the initial stimulus, inherent susceptibility, aversive conditioning, and the individual’s ability to 
adapt. The repeated triggering of sickness to the same stimulus signifies an inability to habituate 
and is a core feature of MSD and VIMSD. An exception is made for stimuli that are extremely 
severe and infrequent such as exposure to parabolic flight or very rough sea conditions. 
6. The usual behavioral response to motion sickness or VIMS is to avoid the sickness-inducing 
motion stimulus or to shorten the duration of exposure, when possible. When neither is possible, 
negative anticipatory emotions or conditioned aversive responses (e.g., anticipatory nausea) may 
occur prior to exposure to the motion stimulus. 
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7. An individual may be diagnosed with MSD, VIMSD, or both.  
3.3 Motion Sickness Susceptibility and Severity
Intense interest in motion sickness and VIMS in the last century has led to the development of a number 
of severity and susceptibility scales. Several scales used for research purposes are presented, with 
common elements listed to show the overlap in queried symptoms (per Criteria 3.1 A) (Table 1 for 
multi-symptom checklists of severity state [12, 31-33][40], Table 2 for single-answer severity state 
questionnaires [49, 50] [51-53] and Table 3 for retrospective scales for trait susceptibility [47, 48, 54]. 
The subcommittee recommends that each scale be used based on its specific advantages to the research 
question or clinical application, e.g. the Motion Sickness Susceptibility Questionnaire (MSSQ-Short) 
form to retrospectively estimate general motion sickness trait susceptibility [48], the first 16 items of the 
Simulator Susceptibility Questionnaire (SSQ) for estimating state VIMS, and the full list of 28 
SSQ/MSQ symptoms for estimating state motion sickness [12]. 
While motion sickness can be induced in nearly all people with a sufficiently strong stimulus, there are 
individuals at the extremes of the population distribution of susceptibility. The distribution curve of 
recollections of past susceptibility is linear up to about the 75Th percentile of susceptibility and flattens 
out on the high end of scores, e.g., on the MSSQ-Short form, out of a total possible score of 54, a score 
of 11=50th percentile, 19=75th percentile, 27=90th percentile, and 31=95th percentile, indicating that only 
a small proportion of people are severely susceptible to motion sickness, i.e. 90% of people score 0-27 
while 10% of people score 28-54 on the MSSQ scale [47]. Norms may be different depending on the 
demographic traits of the population sampled, which should be considered when working with non-
representative populations [55, 56]. 
Though highly susceptible people tend to develop motion sickness to more than one kind of stimulus, 
susceptibility to motion sickness in individuals of normal susceptibility is not a strong predictor of 
susceptibility to VIMS. Prediction could be partially limited by large individual variability in symptom 
type and progression [56]. Nausea and vomiting are typically less common in VIMS, whereas ocular 
motor issues (e.g., eyestrain, blurred vision) and headache are more common in VIMS than in motion 
sickness. Additionally, older adults are more susceptible to VIMS but not to motion sickness than 
younger adults [7, 17, 57]. 
The frequency and severity of motion sickness events can be mitigated by reducing exposure to 
sickness-inducing stimuli (e.g., via avoidance or cessation), modifying behavior during exposure to 
reduce the stimulus impact (e.g., limiting head movements), taking medications prior to exposure, 
maximizing helpful Earth-referenced cues (e.g., via view of the outside world), or by engaging in 
measured amounts of motion exposure in order to induce habituation. Interventions which have been 
tried include habituation exercises (eye-head motion and repeated exposure) [23], pharmacologic 
pretreatments (anti-muscarinic, anti-histaminic, anti-cholinergic medications) [58], non-pharmacological 
treatments (music, smells) [59], and behavioral techniques (breathing exercises, meditation) [60]. It is 
common to hear about ginger or acupressure as motion sickness countermeasures, but the empirical 
evidence for these interventions is mixed [61-65]. The effectiveness of these methods varies widely, 
with the greatest benefit derived from adaptation, medications, and modifying behavior during exposure. 
Habituation is often stimulus-specific, however, and may not generalize across motion situations. 
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3.4 MSD and VIMSD Impact
Motion sickness that is mild, easily avoidable, or has no functional impact is common among 
individuals with normal vestibular function and should not be considered a disorder. However, motion 
sickness susceptibility that affects activities of daily living such as meeting basic transportation needs or 
fulfilling obligations to family, employers, or social contacts can have physical and mental health 
consequences. Even in otherwise healthy individuals, motion sickness can reduce work or school 
productivity and decrease social engagement through direct effects from being ill, avoidance of 
sickness-inducing activities, or sedation induced by motion or by pharmacological motion sickness 
remedies [27, 66, 67]. Nausea, lethargy, and drowsiness can shift attention away from critical tasks, 
while vomiting can lead to dehydration or aspiration [39, 68]. 
Formal disability scales can be paired with existing motion sickness or VIMS scales to quantify 
disability due to MSD or VIMSD. As an example, the Sheehan Disability Scale quantifies impact on 
work, family, or social function on a 10-point scale along with a query of loss of work time or 
productivity due to symptoms [69]. Alternatively, a basic impact assessment that queries whether work, 
social, family, or travel difficulties are experienced (Yes or No) due to symptoms can be used as a quick 
assessment, e.g., the Social Work Impact of Dizziness short form adapted for motion sickness [70, 71]. 
Even if motion sickness or VIMS does not create a disability, it should be recognized as a clinical entity 
that deserves medical attention. In most cases, education, exposure minimization, avoidance of 
exacerbating behaviors, short-term use of anti-motion sickness medications, or simple habituation 
exercises beforehand may be employed to reduce morbidity.  
4. Motion Sickness Clinical Features 
4.1 Prevalence
The prevalence of motion sickness in childhood has been estimated at 35-43% prior to puberty and 25% 
in young adults; it is a frequent problem in 14% of adults younger than 30 years old and 7% of adults 61 
years old or older [72-74]. The prevalence of VIMS ranges widely depending on the stimulus type and 
the visual content, with rates varying from 1% [75] to 60% [76] to 80-95% [77, 78]. 
4.2 Demographics
4.2.1 Age: Susceptibility to motion sickness changes with age. Infants are resistant to motion 
sickness until about age 2, at which point motion sickness susceptibility rises between the ages of 7-12 
years and declines thereafter and throughout adulthood [19, 72, 79]. Susceptibility gradually continues 
to decline with age but may increase in a small proportion of individuals [27]. An increase in 
susceptibility to VIMS as a factor of age has been well-documented, with older adults reporting more 
VIMS than younger adults [55, 80, 81]. Prevalence estimates should consider that people might self-
restrict their behavior and avoid situations that provoke motion sickness if they are aware of their 
elevated susceptibility. 
4.2.2 Sex: The evidence of sex differences in motion sickness is mixed. Only 50% of the studies 
in the literature have found women to be significantly more susceptible to motion sickness [17], with 
estimates varying among studies depending on stimulus type, endpoint studied, age, ethnicity, and 
hormonal status [47, 74, 82-86]. Sex differences in motion sickness are seen more frequently in survey 
studies than in controlled laboratory studies and more commonly in older studies than recent ones [17]. 
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Even among authors positing a sex difference, the estimated effect of sex is only about one-third that of 
age [87, 88]. Secondary hormonal factors such as the use of oral contraceptives, menstruation, 
pregnancy, and cortisol levels correlate with motion sickness susceptibility in women, which further 
complicates the association [87, 89, 90].
Sex differences in VIMS have been observed in some studies [81, 91-93], but it remains unclear 
whether such observations are due to women being more open about reporting than men, are better at 
introspecting than men, or have less experienced with motion than men, among several other 
confounding reasons [17, 92]. A meta-analysis failed to detect any sex differences in VIMS due to 
virtual reality (VR) usage [94] while another study [95] concluded that VIMS sex differences in VR may 
be accounted for by a non-sex-specific variable such as difficulty in fitting the VR properly to people 
with smaller interpupillary distance. A variety of other factors unrelated to sex can affect occurrence of 
VIMS, including technical manipulations such as the size of the field-of-view, video game experience, 
and passive restraints [96-98]. Overall, the case is weak for differences in VIMS that are specific to 
biological male vs. female birth category.
4.2.3 Race and Ethnicity: Studies that assessed motion sickness susceptibility by questionnaire, 
rotation of the body with head pitching, and exposure to optokinetic drums have reported heightened 
susceptibility in people of Asian descent compared to European or African descent [82, 99]. These 
differences persist in American-born children of Asian parents, supporting at least a partial heritable 
component to motion sickness susceptibility[99]. 
Further controlled studies of the ethnic, racial, or cultural components to motion sickness are 
needed. Generalizations concerning these features which could influence decisions about patient care or 
occupational status should be treated with caution.
4.3 Genetics 
Heritability for motion sickness (in women) shows a 0.69 concordance in monozygotic twins and 0.44 
concordance in dizygotic twins for childhood motion sickness, yielding a heritability estimate of 70% 
[72]. A large genome-wide association study involving 80,494 individuals with carsickness found 35 
single nucleotide variants at genome-wide significant levels. The top ten genes involved in these regions 
included: PVRL3, GPD2, ACO1, AUTS2, GPR26, UBE2E2, CBLN4, MUTED, LINGO2 and CPNE4 
[74]. A genetic risk score using the number of risk alleles found on each individual for these 35 variants 
could be used to anticipate motion sickness susceptibility. These genes involve a wide variety of 
functions such as brain, eye, and ear development and even insulin resistance. Some of these loci 
overlap with genes in individuals who experience dizziness, post-operative nausea and vomiting, altitude 
sickness, morning sickness, indigestion to dairy, and headache after red wine [74]. 
4.4. Other Modifying Factors
Other modifying factors may include baseline autonomic tone, glucose levels, and aerobic fitness [100-
102]. It is difficult to predict how these numerous factors, in combination, ultimately impact 
susceptibility in an individual, however.
4.5 Associated Syndromes 
4.5.1 Migraine: Symptoms of migraine and motion sickness overlap in many respects, e.g., 
nausea, stomach awareness, and headache [84, 103]. Motion sickness is self-reported in at least 50% of 
migraine headache sufferers with motion sickness in childhood correlating with eventual development of 
migraine headaches in adolescence and adulthood [47, 104, 105]. These associations suggest that neural 
pathways for nausea and emesis are particularly sensitive in individuals with migraine [47]. Scalp 
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tenderness and nausea during optokinetic stimulation increase more for those who experience migraine 
than for those who do not [106]. Motion sickness induced by OVAR is especially intense in individuals 
with migraine [45]. This type of motion sickness may be blunted by rizatriptan, a migraine abortive 
medication [107, 108]. In contrast, VIMS does not appear to be mitigated by pre-treatment with 
rizatriptan [109]. Individuals with migraine headaches experience both motion sickness and VIMS to a 
higher degree than those without migraine, but the correlation between motion sickness and VIMS in 
this group is weak [110]. 
4.5.2 Structural vestibular disorders: Loss of peripheral vestibular function significantly raises 
the threshold for motion sickness but the role of a functioning vestibulum for VIMS is less clear [45, 
111-113]. Congruently, patients with chronic stable vestibular loss (unilateral and bilateral) report less 
motion sickness on clinical motion sickness ratings than healthy controls. In comparison, patients with 
benign paroxysmal positional vertigo show a non-significant difference in motion sickness susceptibility 
[79]. Patients with vestibular neuritis can experience either an increase or a decrease in motion sickness  
susceptibility after the onset of their disorder, with increased susceptibility in uncompensated cases [45, 
57]. Two studies have shown that individuals with Ménière’s disease are more susceptible to motion 
sickness than healthy controls but are not as susceptible as those with migraine or vestibular migraine 
[114, 115]. There is no correlation between the degree of caloric asymmetry in vestibular patients and 
scores on a clinical motion sickness questionnaire. In contrast, patients with vestibular disorders without 
vestibular loss report higher degrees of motion sickness than controls [45, 104]. About 10-minutes of 
laboratory motion exposure has been shown to distinguish the susceptibility of individuals with different 
vestibular disorders (vestibular neuritis, bilateral vestibulopathy, vestibular migraine) [45].
5. Motion Sickness Laboratory Examinations
Motion sickness may be induced in laboratory settings with approximately 38% of the variability in 
motion sickness in operational settings being explained by an individual’s response to provocative 
laboratory motion tests [54]. Most of these established motion sickness tests are not used for clinical 
diagnosis, however. Correlations between the MSSQ and laboratory-induced nausea by cross-coupled 
stimulation have been reported to be between 0.14 and 0.58, with generally higher correlations seen for 
vertical translational oscillations than horizontal oscillations [47]. Of the translational planes, motion 
through the body-referenced X- or Y-axes (fore-aft or side-to-side motion when upright, respectively) 
are more provocative than the body-referenced Z-axis, (up-down) but motion direction with respect to 
the gravity vector (e.g. vertical versus horizontal) is a less important factor [116]. 
An area of controversy is whether a smaller phase lead of the vestibulo-ocular reflex (VOR), which 
indicates enhanced velocity storage, is related pathophysiologically to motion sickness susceptibility, as 
found in some laboratories [116-120] but not others [88, 107]. The mixed findings may relate to the 
degree of habituation to the motion stimulus [121]. It has been proposed that the absolute value of the 
VOR may not be the relevant marker of motion sickness susceptibility, but rather the ability to modify 
the VOR in response to varying motion sickness-inducing stimuli [27, 88]. The relationship between 
motion sickness susceptibility and adaptability of vestibular responses has also been supported by lower 
cervical vestibular evoked myogenic potential (VEMPS) thresholds correlating with the ability to 
habituate to seasickness; this may be attributable to the wider potential range of adaptive responses to 
motion stimuli with lower VEMP thresholds [122].
6. Differential Diagnosis 
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Because motion sickness susceptibility in a healthy person generally declines with age, an adult 
presenting with increasing susceptibility to motion should be evaluated for underlying causes of a 
lowered threshold for motion sickness.  This evaluation may include an assessment for vestibular 
disorders, migraine, endocrine abnormalities, ocular misalignment, and other central nervous system 
disorders. Head motion-induced discomfort (when not undergoing passive whole-body motion) should 
be suspected as being secondary to an uncompensated vestibular asymmetry and evaluated with 
vestibular laboratory testing, unless such discomfort is directly related to the aftereffects of prolonged 
adaptation to motion (e.g., return to land after a voyage at sea). Similarly, abrupt changes in VIMS 
should prompt careful evaluations for ocular and ocular motility problems. Clinicians should be aware 
that head motion during certain types of uncompensated vestibular pathology or by healthy persons 
during challenging motions or within unusual force environments (such as space) can each elicit similar 
symptoms of nausea, headache, dizziness, vertigo, oscillopsia, or visual blurring, so these symptoms 
cannot be assumed to definitively differentiate between vestibular pathology and motion sickness 
without further inquiry concerning when the symptoms appeared (e.g., relative to the last motion 
experience), under what conditions they appeared (e.g., the type and duration of the motion experience), 
and what additional symptoms were present [43]. Finally, while a motion sickness disorder would be 
more strongly suspected in a younger person scoring high on the MSSQ or a VIMS disorder in an older 
individual scoring high on the SSQ, individual variability in motion sickness and VIMS susceptibility is 
high, so clinicians should be cautious not to over-generalize from demographical findings.
7. Future Directions
The presentation of these criteria for motion sickness acknowledges that there are still critical 
information gaps to be filled in order to determine a clear demarcation between motion sickness and 
VIMS as normal human responses to motion stimuli versus these responses representing a disorder. The 
difficulty in determining this distinction in no small part lies in the large number of variables that 
contribute to inherent (trait) susceptibility, comorbidity, and variability of the stimulus each person 
experiences. 
A challenge in motion sickness and VIMS research has been the rapid technological advancements in 
transportation and entertainment options that have created an environment of increasing motion stimuli 
in both novelty and number [123]. It remains to be determined whether human beings may be able to 
push current boundaries of motion tolerance through enhanced habituation exercises, helpful Earth-
referenced sensory cues, manipulation of vestibular input, cognitive enhancement techniques, 
pharmacological therapies, or noninvasive brain stimulation methods. Prediction of susceptibility based 
on demographics, hormonal rhythms, genetics, and physiological status may lead to optimization of 
environments that reduce stimulus intensity and morbidity. Toward those ends, criteria for motion 
sickness/VIMS and MSD/VIMSD have been proposed here to promote clearer communication among 
clinicians and investigators. These criteria are expected to evolve as data on epidemiology, natural 
history, biomarkers, and assessments of future health consequences are methodically acquired.
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Table 2: Single Answer Motion Sickness Severity Scales   
Table 3: Retrospective Motion Sickness Trait Susceptibility Scales 
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